BLRX
BioLineRx Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.49
−1.70%Margins
Gross margin
36.2%
EBITDA margin
-18.9%
EBIT margin
-871.8%
Net margin
-99.6%
FCF margin
-686.4%
-8.6%
Return on equity
-3.5%
Return on assets
-47.8%
Return on invested capital
0.03x
Asset turnover
-$8.1M
Cash from operations
$2.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026